MEMANTINE RANBAXY memantine hydrochloride 20 mg tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

memantine hydrochloride, Quantity: 20 mg

Disponibbli minn:

Sun Pharma ANZ Pty Ltd

INN (Isem Internazzjonali):

memantine hydrochloride

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: purified talc; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

28

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Treatment of the symptoms of moderately severe to severe Alzheimer's disease

Sommarju tal-prodott:

Visual Identification: Pale red to grey red, oval-shaped, film-coated tablets, debossed with M14 on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2013-11-28